Evidence supporting the use of: Vitamin D3
For the health condition: Lupus

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Vitamin D3 (cholecalciferol) is used to support patients with systemic lupus erythematosus (SLE) based on a growing body of scientific evidence. Research has shown that people with lupus are often deficient in vitamin D, likely due to photosensitivity and avoidance of sunlight, which is the primary natural source of vitamin D. Low vitamin D levels in lupus patients are associated with increased disease activity, higher risk of flares, and possibly more severe symptoms. Several observational studies and some interventional trials suggest that vitamin D supplementation may help modulate immune function, reduce disease activity, and improve patient outcomes in SLE.

Vitamin D plays a role in immune regulation by influencing both innate and adaptive immune responses. It is thought to promote tolerance and reduce the production of autoantibodies, which are central to lupus pathogenesis. Some randomized controlled trials and meta-analyses (such as those published in Lupus and Autoimmunity Reviews) have reported modest benefits on disease markers, fatigue, and quality of life in lupus patients receiving vitamin D supplementation, although results are not entirely consistent and the effect size is generally moderate.

Overall, while vitamin D3 is not a primary treatment for lupus, supplementation is justified on the basis of correcting deficiency and potentially supporting immune regulation. Current guidelines recommend monitoring vitamin D levels and supplementing as needed in lupus patients. More large-scale, high-quality trials are needed to confirm the extent of benefit for disease activity.

More about vitamin D3
More about Lupus